These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14491888)

  • 21. Copper excretion in the urine of normal individuals and of patients with hepatolenticular degeneration (Wilson's disease).
    PORTER H
    Arch Biochem Biophys; 1951 Apr; 31(2):262-5. PubMed ID: 14830233
    [No Abstract]   [Full Text] [Related]  

  • 22. THE LOCALIZATION OF COPPER IN THE PERICANALICULAR GRANULES (LYSOSOMES) OF LIVER IN WILSON'S DISEASE (HEPATOLENTICULAR DEGENERATION) .
    GOLDFISCHER S
    Am J Pathol; 1965 Jun; 46(6):977-83. PubMed ID: 14328025
    [No Abstract]   [Full Text] [Related]  

  • 23. Observations on ceruloplasmin in Wilson's disease.
    SASS-KORTSAK A; CHERNIAK M; GEIGER DW; SLATER RJ
    J Clin Invest; 1959 Oct; 38(10 Pt 1-2):1672-82. PubMed ID: 14441876
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatolenticular degeneration--is the term too narrow to explain Wilson's disease?
    Fatima J; Karoli R; Siddiqui Z; Chandra A; Jain V
    J Assoc Physicians India; 2014 Jun; 62(6):531-3. PubMed ID: 25856923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Copper levels in the tissues of patients with Wilson's disease].
    Petrovecki V; Kovacić Z; Pizent A; Jakić-Razumović J
    Arh Hig Rada Toksikol; 1997 Jun; 48(2):241-6. PubMed ID: 9471969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [COPPER METABOLISM AND WILSON'S DISEASE].
    LANGE J
    Verh Dtsch Ges Inn Med; 1964; 70():330-7. PubMed ID: 14294237
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet.
    Goldstein NP; Tauxe WN; McCall JT; Gross JB; Randall RV
    Trans Am Neurol Assoc; 1969; 94():34-7. PubMed ID: 5374484
    [No Abstract]   [Full Text] [Related]  

  • 28. Copper removal strategies for Wilson's disease crisis in the ICU.
    Reynolds HV; Talekar CR; Bellapart J; Leggett BA; Boots RJ
    Anaesth Intensive Care; 2014 Mar; 42(2):253-7. PubMed ID: 24580393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathophysiology of Wilson's disease.
    REILLY RW
    Med Clin North Am; 1963 Jan; 47():207-17. PubMed ID: 13973797
    [No Abstract]   [Full Text] [Related]  

  • 30. Ultrastructural pathology with normal light microscopy of liver in Wilson's disease. A case report.
    Enat R; Lichtig C; Segman S; Hemli JA; Barzilai D
    Isr J Med Sci; 1979 Jun; 15(6):485-9. PubMed ID: 457381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Occurrence of copper metabolism abnormalities in the families of four individuals with newly diagnosed Wilson's disease].
    Dastych M
    Vnitr Lek; 1997 Feb; 43(2):87-90. PubMed ID: 9245074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hepatocerebral degeneration: Westphal-Strümpeli pseudosclerosis; Wilson's disease; hepatolenticular degeneration; abdominal Wilson's disease].
    CARRARA E
    Riv Patol Nerv Ment; 1952; 73(1):133-50. PubMed ID: 14950047
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies of cholecystokinin-stimulated biliary secretions reveal a high molecular weight copper-binding substance in normal subjects that is absent in patients with Wilson's disease.
    Iyengar V; Brewer GJ; Dick RD; Chung OY
    J Lab Clin Med; 1988 Mar; 111(3):267-74. PubMed ID: 3125292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wilson's disease: a new gene and an animal model for an old disease.
    Cuthbert JA
    J Investig Med; 1995 Aug; 43(4):323-36. PubMed ID: 7552582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Copper distribution in Wilson's disease.
    Stömmer PE
    Arch Pathol Lab Med; 1983 Oct; 107(10):554. PubMed ID: 6688520
    [No Abstract]   [Full Text] [Related]  

  • 37. Tracing copper-thiomolybdate complexes in a prospective treatment for Wilson's disease.
    Zhang L; Lichtmannegger J; Summer KH; Webb S; Pickering IJ; George GN
    Biochemistry; 2009 Feb; 48(5):891-7. PubMed ID: 19146437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wilson's disease.
    Bearn AG
    Am J Clin Nutr; 1961; 9():695-9. PubMed ID: 13866167
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experiments on the pathogenesis of Wilson's disease. 4. The action of alpha-lipoic acid on the metabolism of copper and proteins in cases of hepatolenticular degeneration (recent observations)].
    da COSTA S; RODRIGUES EM; da SILVA J; RELVAS ME; HALPERN MJ
    Gaz Med Port; 1960; 13():706-22. PubMed ID: 13695799
    [No Abstract]   [Full Text] [Related]  

  • 40. WILSON'S DISEASE (HEPATO-LENTICULAR DEGENERATION): A BRIEF REVIEW.
    HELLER GL
    Psychiatry Dig; 1965 Mar; 26():33-9. PubMed ID: 14256542
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.